{
    "Trade/Device Name(s)": [
        "CoaguSense Self-Test PT/INR Monitoring System",
        "CoaguSense Self-Test Prothrombin Time/INR Monitoring System"
    ],
    "Submitter Information": "CoaguSense, Inc.",
    "510(k) Number": "K093243",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050243",
        "K021923",
        "K072727",
        "K030845"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "April 7, 2010",
    "Summary Letter Received Date": "March 4, 2010",
    "Submission Date": "March 2, 2010",
    "Regulation Number(s)": [
        "21CFR864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time",
        "International Normalized Ratio (INR)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CoaguSense Self-Test PT/INR Monitoring System meter"
    ],
    "Method(s)/Technology(ies)": [
        "Clot detection (mechanical/optical with rotating spoked wheel and infrared light beam)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Reagent",
        "Strip",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for CoaguSense Self-Test PT/INR Monitoring System for self-testing of prothrombin time and INR in capillary whole blood using a portable meter.",
    "Indications for Use Summary": "Provides quantitative prothrombin time (PT) and INR results using capillary whole blood for self-testing by warfarin-anticoagulated patients or their caregivers as directed by a physician; not for screening purposes.",
    "fda_folder": "Hematology"
}